Two days after induction chemotherapy for Burkitt lymphoma, a 22-year-old man develops oliguria. Investigations show potassium 6.8 mmol/L, phosphate 2.9 mmol/L, calcium 1.6 mmol/L, uric acid 890 µmol/L and creatinine 340 µmol/L. Along with hydration, which drug directly addresses the underlying enzyme deficiency exploited here?
- A Allopurinol
- B Febuxostat
- C Sodium polystyrene sulfonate
- D Rasburicase ✓
Explanation
This is tumour lysis syndrome: rapid cell lysis releases potassium, phosphate and nucleic acids that are metabolised to uric acid, precipitating obstructive uric acid nephropathy. Humans lack urate oxidase, so urate crystals form readily; rasburicase is recombinant urate oxidase that converts uric acid to soluble allantoin. Allopurinol and febuxostat only prevent new uric acid formation and do not clear the already elevated load.
Reference: Harrison's Principles of Internal Medicine, 21st ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.